The Joint Corp.

NasdaqCM:JYNT Voorraadrapport

Marktkapitalisatie: US$176.1m

Joint Balans Gezondheid

Financiële gezondheid criteriumcontroles 6/6

Joint heeft een totaal eigen vermogen van $20.5M en een totale schuld van $0.0, wat de schuld-eigenvermogensverhouding op 0% brengt. De totale activa en totale passiva bedragen respectievelijk $79.6M en $59.1M. De EBIT Joint is $2.9M waardoor de rentedekking -14.1 is. Het heeft contanten en kortetermijnbeleggingen van $20.7M.

Belangrijke informatie

0%

Verhouding schuld/eigen vermogen

US$0

Schuld

Rente dekkingsratio-14.1x
ContantUS$20.74m
AandelenUS$20.48m
Totaal verplichtingenUS$59.12m
Totaal activaUS$79.60m

Recente financiële gezondheidsupdates

Does Joint (NASDAQ:JYNT) Have A Healthy Balance Sheet?

Oct 27
Does Joint (NASDAQ:JYNT) Have A Healthy Balance Sheet?

These 4 Measures Indicate That Joint (NASDAQ:JYNT) Is Using Debt Reasonably Well

Jul 22
These 4 Measures Indicate That Joint (NASDAQ:JYNT) Is Using Debt Reasonably Well

Does Joint (NASDAQ:JYNT) Have A Healthy Balance Sheet?

Feb 08
Does Joint (NASDAQ:JYNT) Have A Healthy Balance Sheet?

Recent updates

The Joint Corp.'s (NASDAQ:JYNT) Price Is Out Of Tune With Revenues

Sep 14
The Joint Corp.'s (NASDAQ:JYNT) Price Is Out Of Tune With Revenues

The Joint Corp. (NASDAQ:JYNT) Shares Could Be 22% Above Their Intrinsic Value Estimate

Aug 05
The Joint Corp. (NASDAQ:JYNT) Shares Could Be 22% Above Their Intrinsic Value Estimate

Investors Could Be Concerned With Joint's (NASDAQ:JYNT) Returns On Capital

Jul 17
Investors Could Be Concerned With Joint's (NASDAQ:JYNT) Returns On Capital

Optimistic Investors Push The Joint Corp. (NASDAQ:JYNT) Shares Up 26% But Growth Is Lacking

May 04
Optimistic Investors Push The Joint Corp. (NASDAQ:JYNT) Shares Up 26% But Growth Is Lacking

The Joint Corp.'s (NASDAQ:JYNT) Share Price Not Quite Adding Up

Mar 10
The Joint Corp.'s (NASDAQ:JYNT) Share Price Not Quite Adding Up

Returns Are Gaining Momentum At Joint (NASDAQ:JYNT)

Feb 12
Returns Are Gaining Momentum At Joint (NASDAQ:JYNT)

Joint (NASDAQ:JYNT) Shareholders Will Want The ROCE Trajectory To Continue

Jun 17
Joint (NASDAQ:JYNT) Shareholders Will Want The ROCE Trajectory To Continue

Joint's (NASDAQ:JYNT) Returns On Capital Are Heading Higher

Jan 04
Joint's (NASDAQ:JYNT) Returns On Capital Are Heading Higher

Does Joint (NASDAQ:JYNT) Have A Healthy Balance Sheet?

Oct 27
Does Joint (NASDAQ:JYNT) Have A Healthy Balance Sheet?

The Joint Corp. Can Relieve You From High Inflation Pain

Oct 17

The Joint Corp.: Weakening Bottom-Line Fundamentals Unsupportive In Current Landscape

Aug 05

These 4 Measures Indicate That Joint (NASDAQ:JYNT) Is Using Debt Reasonably Well

Jul 22
These 4 Measures Indicate That Joint (NASDAQ:JYNT) Is Using Debt Reasonably Well

Returns Are Gaining Momentum At Joint (NASDAQ:JYNT)

Jun 29
Returns Are Gaining Momentum At Joint (NASDAQ:JYNT)

Is There Now An Opportunity In The Joint Corp. (NASDAQ:JYNT)?

Jun 14
Is There Now An Opportunity In The Joint Corp. (NASDAQ:JYNT)?

Joint's (NASDAQ:JYNT) Sluggish Earnings Might Be Just The Beginning Of Its Problems

Mar 03
Joint's (NASDAQ:JYNT) Sluggish Earnings Might Be Just The Beginning Of Its Problems

Should You Be Adding Joint (NASDAQ:JYNT) To Your Watchlist Today?

Feb 23
Should You Be Adding Joint (NASDAQ:JYNT) To Your Watchlist Today?

Does Joint (NASDAQ:JYNT) Have A Healthy Balance Sheet?

Feb 08
Does Joint (NASDAQ:JYNT) Have A Healthy Balance Sheet?

Joint Corp.: Solid Q4 Results From This Small-Cap Growth Story

Jan 30

Joint (NASDAQ:JYNT) Shareholders Will Want The ROCE Trajectory To Continue

Jan 24
Joint (NASDAQ:JYNT) Shareholders Will Want The ROCE Trajectory To Continue

What Does The Joint Corp.'s (NASDAQ:JYNT) Share Price Indicate?

Jan 08
What Does The Joint Corp.'s (NASDAQ:JYNT) Share Price Indicate?

Do Joint's (NASDAQ:JYNT) Earnings Warrant Your Attention?

Nov 23
Do Joint's (NASDAQ:JYNT) Earnings Warrant Your Attention?

Is Joint (NASDAQ:JYNT) A Risky Investment?

Nov 08
Is Joint (NASDAQ:JYNT) A Risky Investment?

Joint (NASDAQ:JYNT) Shareholders Will Want The ROCE Trajectory To Continue

Oct 21
Joint (NASDAQ:JYNT) Shareholders Will Want The ROCE Trajectory To Continue

Is The Joint Corp. (NASDAQ:JYNT) Potentially Undervalued?

Oct 05
Is The Joint Corp. (NASDAQ:JYNT) Potentially Undervalued?

Analyse van de financiële positie

Kortlopende schulden: De korte termijn activa ( $55.2M ) JYNT } overtreffen de korte termijn passiva ( $38.3M ).

Langlopende schulden: De kortetermijnactiva JYNT ( $55.2M ) overtreffen de langetermijnschulden ( $20.8M ).


Schuld/ eigen vermogen geschiedenis en analyse

Schuldniveau: JYNT is schuldenvrij.

Schuld verminderen: JYNT heeft geen schulden vergeleken met 5 jaar geleden, toen de schuld/eigen vermogen-ratio 26.3% was.


Balans


Analyse van de cashflow

Voor bedrijven die in het verleden gemiddeld verliesgevend zijn geweest, beoordelen we of ze ten minste 1 jaar kasstroom hebben.

Stabiele cash runway: Terwijl het verlieslatende JYNT voldoende cash runway heeft voor meer dan 3 jaar, als het zijn huidige positieve vrije kasstroom-niveau behoudt.

Voorspelling contante baan: JYNT is verlieslatend, maar heeft voldoende kasmiddelen voor meer dan 3 jaar, omdat de vrije kasstroom positief is en met 11.8 % per jaar groeit.


Ontdek gezonde bedrijven